Pitt, Wake Forest Team Discovers Why Stored Blood May Become Less Safe For Transfusion As It Ages
7/13/2011
Transfused blood may need to be stored in a different way to prevent the breakdown of red blood cells that can lead to complications including infection, organ failure and death, say researchers at the University of Pittsburgh School of Medicine and Wake Forest University...
Know Your Familial Cancer History, Key Factor In Early Detection
7/13/2011
Know your history. Period. When your family history changes, or new forms of cancer arise in your bloodline, tell your doctor...
Harnessing The Body's Own Chemistry To Treat Human Ovarian Cancer
7/13/2011
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that a low dose of the opioid antagonist naltrexone (LDN) has an extraordinarily potent antitumor effect on human ovarian cancer in tissue culture and xenografts established in nude mice. When LDN is combined with chemotherapy, there is an additive inhibitory action on tumorigenesis...
the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate® system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its ExAblate® system in clinical trials, showing promising initial results...
CYTAVIS' Aviscumine Improves Survival Of Patients With Metastatic Melanoma In A Phase II Trial
7/13/2011
CYTAVIS BioPharma GmbH, a biopharmaceutical company developing derivatives of natural compounds for the treatment of oncological and immunological diseases, today announced Phase II data demonstrating that its lead compound Aviscumine (CY503), an immune potentiator, may improve survival of patients with refractory metastatic melanoma (stage IV)...
Drugs Of The Indirubin Family May Improve Survival In Glioblastoma
7/13/2011
The active ingredient in a traditional Chinese herbal remedy might help treat deadly brain tumors, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James)...
Scientists Discover DNA Regions Influencing Prostate Cancer Risk
7/13/2011
Doctors have known for a long time that prostate cancer "runs in the family". Men with relatives who have been diagnosed with prostate cancer have an elevated risk of also developing this type of cancer...
Contact Allergies May Help Immune System Defend Against Cancer
7/13/2011
Contact allergies, that is the skin rashes and irritations that some people get when they come into contact with certain metals like nickel, or chemicals or other substances like hair dye and latex rubber, may trigger the immune system into defending against some types of cancer, according to new research from Denmark that was published online this week in BMJ Open...
Cancer Mortality Rates Are Higher In Men Than Women
7/13/2011
Overall cancer mortality rates are higher for men than women in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Michael B. Cook, Ph.D., an investigator in the division of cancer epidemiology and genetics at the National Cancer Institute, and colleagues used U.S...
The Orthopedic Clinic and Policlinic at the University Medical Center of Johannes Gutenberg University Mainz (JGU) has recently deployed a new system for the treatment of spinal tumors for the first time...